Thyroid concerns and cancer risk Both semaglutide and tirzepatide carry a black box warning about medullary thyroid carcinoma (MTC) risk
However, the transition is not always seamless
Now theyve moved on to maintenance microdosing to reduce the risks from other health problems like heart disease
The absence of a gallbladder does not fundamentally alter how semaglutide works in the body, as this glucagon-like peptide-1 (GLP-1) receptor agonist primarily acts on the pancreas, brain, and gastrointestinal tract rather than the biliary system directly
The FDA ended the shortage February 21, 2025, and clarified on April 1, 2026 that B12 add-ons alone do not automatically qualify a script
Therefore, when using semaglutide, adverse reactions occur earlier with oral administration compared to subcutaneous injection ( Our study findings confirm the conclusions drawn from current epidemiological research